VEGFA and COVID-19: Here, we investigated the underlying mechanisms involved in SARS‐CoV‐2 spike‐induced VEGF production and inflammation in the intestine, which may provide therapeutic targets for the remediation of GI symptoms in patients with COVID‐19.